NCT Number: NCT02420886
Adding Cytokines to In Vitro Human Culture Media to Improve Embryogenesis and Implantation
Assessment of the embryological benefit of in vitro adding of Cytokines (LIF 5ng/ml, HB-EGF 5ng/ml and GM-CSF 2n/ml) to the culture media and closely monitor its effect on embryogenesis and implantation outcomes.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–40 year
Sex eligibility
Female
Study type
Interventional
Phase
Not applicable
Primary location
Banon IVF Center, Asyut, Egypt
About this study
The IVF culture media design and upgrade underwent many ideas during the last 3 decades, we suppose that adding the Cytokines (LIF 5ng/ml, HB-EGF 5ng/ml and GM-CSF 2ng/ml) as a growth factor that have multi-ways to might improve embryo development in vitro so we decide to design a trial to compare the embryogenesis by sibling Oocytes of the same patient between two arm of the same culture media and the same culture condition. One arm with Cytokines and the other is traditional one and closely monitor the outcome within the 2 arms and record the results.
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- all patients
Exclusion criteria
- over 40 years
Treatment and study plan
Primary outcomes
-
ongoing pregnancy rate ( % )
Time frame: 6 months
Secondary outcomes
-
clinical pregnancy rate ( % )
Time frame: 6 months
-
implantation rate
Time frame: 6 months
-
fertilization rate
Time frame: 6 days of culture
-
top-quality embryo rate
Time frame: 6 days of culture
-
rates for blastocyst formation and quality
Time frame: 6 days of culture
-
embryo utilization rate
Time frame: 6 days of culture
Sponsors and collaborators
Lead sponsor
Ibn Sina Hospital
Other Gov
Collaborators
- Banon IVF Center Assiut, Egypt
Registry information
Official study title
The Effects of GM-CSF, HB-EGF and LIF Cytokines Supplementation Need Verification for Human Embryo Development in Vitro
Acronym: GHLCSHED
Important dates
- Study start
- 2015
- Primary completion
- 2016
- Study completion
- 2016
- First posted
- Apr 20, 2015
- Registry last updated
- Oct 2, 2018
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Pharmacokinetics of FSH and hCG Following Multiple Dose of Gonadotropins-IBSA.
NCT06659692
Genital Diseases, Infertility
Toronto, Ontario, Canada
View Trial DetailsEvaluation of the Uterine Cavity After Operative Hysteroscopy
NCT06924437
Abnormal Uterine Bleeding (AUB), Endometrial Polyp
Sohag, Egypt
View Trial DetailsHormonal Regulation of Puberty and Fertility
NCT01511588
Adolescents, Amenorrhea
Bethesda, Maryland, United States
View Trial DetailsClinical Investigation of Herbal Formulation and Its Efficacy in Polycystic Ovarian Syndrome
NCT07399535
Adnexal Diseases, Cysts
Karachi, Sindh, Pakistan
View Trial Details